The mission of the US Department of Health & Human Services’ “Operation Warp Speed” is not lacking in ambition: the effort to accelerated COVID-19 vaccines, therapeutics and diagnostics was hailed by President Trump as “a massive scientific, industrial, and logistical endeavor unlike anything our country has seen since the Manhattan Project” during the formal unveiling event at the White House on May 15.
Still, the event felt a bit anticlimactic: the project had been discussed widely in general terms previously, and the top leadership – former GlaxoSmithKline executive Moncef Slaoui as scientific lead and US Army General Gustave Perna as head of logistics and operations – had been disclosed in the days before
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?